Search

Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

Read More About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

Beginning April 29, Renown Pharmacy – Pringle Will Be Open 24/7 Weeks after the only 24/7 pharmacy in Reno-Sparks announced it is no longer open overnight, Renown steps up to fill the community’s need, offering peace of mind knowing that any time, day or night, people can fulfill their essential medication prescriptions at Renown Pharmacy. Renown Health is pleased to announce that beginning on Monday, April 29, Renown Pharmacy - Pringle will expand hours to serve as the only 24/7 pharmacy in the area to serve all customers. The Renown Pharmacy located inside Renown Regional Medical Center will fill a gap left in the community after Walgreens on N. Virginia Street in Reno announced that they will no longer operate on a 24-hour, seven day a week schedule. Renown’s “all-hours, around the clock” pharmacy access will allow patients post-discharge from any area hospital the ability to fill their pharmaceutical prescriptions at any time, along with granting all community members the opportunity to pick up their prescriptions when it is most convenient for them. “We are proud to be able to step up to provide round-the-clock access to essential medications and healthcare services for our growing community, said Brian Erling, MD, MBA, President & CEO for Renown Health. “We understand the importance of accessibility to medications and healthcare support, especially during times of urgent need. Our decision to operate our pharmacy 24 hours a day, 7 days a week, reflects our commitment to serving the needs of our community and ensuring individuals have convenient access to the care they need, day and night.” “We are grateful for the pharmacy service that Walgreens provided the Reno-Sparks area for many years. We are excited that Renown can now provide our community with access to 24/7 Rx care,” said Adam Porath, Pharm.D., BCACP, BCPS, FASHP, Renown Health Vice President of Pharmacy Services. “By offering continuous pharmacy services, we aim to provide peace of mind to our customers and community- knowing that they can rely on us, any time, day, or night, to fulfill their prescription needs and offer professional guidance on medication management. Our talented team of pharmacists and techs are eager to serve our community with the Renown Pharmacy at Renown Regional Medical Center, starting Monday, April 29.” “In times of illness, timely access to medications is crucial for effective treatment and swift recovery. Whether its managing chronic conditions or addressing acute symptoms, adhering to prescribed medication schedules can significantly impact one’s health outcomes,” said Bill Plauth, MD, MMM, CPE, Chief Medical Officer for Renown Health. We believe that by extending our pharmacy hours, we can better support the health and well-being of our community, ensuring they receive care they deserve when they need it most. We invite our people to take advantage of our expanded pharmacy and experience the convenience and reliability of our 24/7 services.” Renown Pharmacy - Pringle is conveniently located on the first floor of Renown Regional Medical Center in Reno. The Renown Pharmacy is near Starbucks and specializes in hard-to-find pharmaceuticals at lower costs, such as certain compound medications not typically stocked at other retail locations. Prescriptions can be transferred to any of Renown’s three retail pharmacy locations by calling the most convenient location and allowing expert pharmacy staff to complete the process. You can then request refills and check your prescription status in the MyChart app. Renown Pharmacy Pringle, 75 Pringle Way: 775-982-7737 Renown Pharmacy South Meadows, 10101 Double R Blvd.: 775-982-5366 Renown Pharmacy Locust, 21 Locust St.: 775-982-5280 For full pharmacy information, visit: renown.org/pharmacy/. Renown Health continues to expand and hire in-demand clinical positions, including positions at Renown Pharmacy. Visit renown.org/careers to learn more.     About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®.

Read More About Filling The Community’s Need for a 24/7 Pharmacy

The study could expand to a quarter million people, making Nevada the only state in the U.S. to offer such a program. Las Vegas, Nev. (May 2, 2019) – The Healthy Nevada Project, a first-of-its-kind, community-based population health study combining genetic, clinical, environmental and social data, is expanding enrollment to Las Vegas. The Project aspires not only to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile but ultimately, to develop and expand the Project for communities across the United States to drive positive health outcomes nationwide.   Adding 25,000 Study Volunteers in Southern Nevada The Healthy Nevada Project is announcing a statewide expansion – opening 25,000 testing slots in Las Vegas. With southern Nevada welcoming the study, the Healthy Nevada Project will offer no-cost genetic testing through a simple spit sample to 25,000 study volunteers. Study volunteers will take Helix’s clinical-grade DNA saliva test and will receive their ancestry and traits, at no cost, through the My Healthy Nevada Traits app. Participants will then be given a chance to answer a follow-up health survey from Renown Institute for Health Innovation (Renown IHI), and upon survey completion, will be entered to win an iPhone. In addition, study participants can agree to be notified about genetic test results that could impact their health, and which could be used to improve their medical care. This return of clinical results, plus genetic counseling and other genetic services as appropriate, will be provided by Genome Medical, the leading network of clinical genetics specialists.   Healthy Nevada Project’s Evolution & Ongoing Expansion With more than 35,000 study participants enrolled in just over two years, the Healthy Nevada Project has become the fastest-enrolling genetic study in the country. The Project was created by Renown IHI – a collaboration between Reno, Nev.-based not-for-profit health network, Renown Health, and the world leader in environmental data, Desert Research Institute (DRI). Leveraging Renown’s forward-thinking approach to community health care and DRI’s data analytics and environmental expertise, Renown IHI has grown its capabilities to lead a larger, more complex research study of significance that will analyze and model public health risks in Nevada and serve as a national model for future population health studies working to improve overall health through clinical care integration. During the Project’s pilot launch in September 2016, more than 10,000 community members signed up for DNA testing in just 48 hours. In March 2018, phase two offered full genomic sequencing through a simple spit test from Helix to northern Nevadans. In October 2018, the Project announced the return of clinical results for study participants, notifying them of their risk for CDC Tier 1 conditions including familial hypercholesterolemia, BRCA positive 1 and 2, and Lynch syndrome, a precursor to colon cancer. These conditions affect more than one percent of the population and are inherited so they impact family members as well. Now, the Project announced its next phase – expanding enrollment to 25,000 people in southern Nevada.   Serving as a National Model This expansion to Las Vegas truly makes this the “Healthy Nevada Project” with a statewide impact making Nevada the only state in the U.S. to offer such a program. “Nevada was ripe to advance population health goals because, sadly, our state ranks near the bottom in health outcomes. The Healthy Nevada Project is working to change that,” said Anthony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health and president of Renown IHI. “Our researchers are working on a number of clinical programs and scientific studies to determine why in Washoe County, the county in which Renown Health is located, Nevada’s age-adjusted death rates for heart disease, cancer and chronic lower respiratory disease are 33 percent higher than the national rate. Imagine if we can gather more data like this on a national scale and use it to change the future of health and health care? That is what the Healthy USA Project is looking to do in the years to come.” “The Healthy Nevada Project is committed to providing study participants clinically actionable data that will help improve their health,” said Joseph Grzymski, Ph.D., associate research professor at DRI, principal investigator of the Healthy Nevada Project and chief scientific officer for Renown Health. “We are providing this information at the individual level so study volunteers can make lifesaving changes to reduce their risk. We’re also doing it on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country.”   Expanding to Become the Healthy USA Project The accelerated speed of the Project is made possible thanks to the ever-decreasing cost of sequencing. Today, Helix is able to sequence an entire exome – which allows reporting on most actionable genomic knowledge – for a fraction of what it would have cost just 10 years ago. Additionally, advances in digital health mean Helix and Project researchers can capture unprecedented amounts of health data digitally, making significant contributions to advancing precision health. The partnership has managed to remove the traditional barriers of population health studies, including the difficulty in recruiting participants, establishing quality high through put lab systems, and scaling interpretation and return of results. This development will be key as other health systems around the country join the Project. “We are thrilled to see the constant, fast-paced evolution of this Project with Renown IHI,” said Justin Kao, CoFounder of Helix. “In less than a year, we have sequenced the DNA of thousands of study participants and are now preparing to offer this incredible study in other states. Combining environmental, clinical, social and genetic data allows us to discover risk factors within communities and help people take action to live longer, healthier lives. That’s what makes the next step of the Healthy USA Project so exciting for all of us. ”Full details on study’s evolution and southern Nevada enrollment will be revealed at a press event in Las Vegas on Tuesday, May 7 at 3 p.m.     Renown Institute for Health Innovation  Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at https://healthynv.org/.  Helix is a genomics company with a simple but powerful mission: to empower every person to improve their life through DNA. Our affordable, turnkey population health solution enables institutions to quickly scale projects that engage communities and accelerate research and discovery, ultimately allowing every person to benefit from the power of genomics. We've also created the first marketplace for DNA-powered products where people can explore diverse and uniquely personalized products developed by high-quality partners, providing powerful tools to increase engagement and speed the pace of population-scale genomics. Helix is headquartered in the San Francisco Bay Area, has an office in Denver, Colorado and operates a CLIA-certified and CAP-accredited next-generation sequencing lab in San Diego powered by Illumina (NASDAQ: ILMN) NGS technology. Helix was created in 2015. Learn more at www.helix.com.  Helix, the Helix logo and Exome+ are trademarks of Helix Opco, LLC. All other trademarks referenced herein are the property of their respective owners.   Additional Media Contacts: Tracy Bower                                                                                                                                                                          DRI                                                                                                                                                                                      702-862-5404                                                                                                                                                      media@dri.edu Eric Schubert                                                                                                                                                                        Seismic for Helix                                                                                                                                                                    415-939-4366                                                                                                                                                    press@helix.com

Read More About Population Health Study Goes Statewide and Opens Enrollment

Despite numerous medical challenges, Emmalee Sutton is a determined, bright and outgoing 14-year-old with a joy for life and passion for helping others. Renown Children’s Hospital and Children’s Miracle Network Hospitals (CMNH) are excited to announce Emmalee Sutton as the 2021 Champion Child Ambassador. A fighter from a very young age, 14-year-old Emmalee has been a source of hope and inspiration to everyone she meets, never letting her medical challenges slow her down.  A video introducing Emmalee and her journey can be found here.  Emmalee was diagnosed with autoimmune hepatitis at age 2, and she has endured a long road of illnesses and hospitalizations since. She also has Addison’s disease, which means her body under-produces critical hormones. She had her gallbladder removed at age 8, port surgery at 13, and has received several liver biopsies over the years.  Over time, heavy steroid use has stunted her growth — at 14 years old, she is 49 inches tall. It has also caused extreme weight gains and losses. She also faces daily issues with her calcium, potassium and sodium levels. Due to her lack of immunities, she is unable to attend school in-person but is on the home/hospital program through the Washoe County School District. Despite Emmalee’s medical challenges, her sheer joy and spark for life remains untouched.  “I am so honored to be chosen as the 2021 Champion Child Ambassador and represent all the kids at Renown Children’s Hospital. I hope my story can inspire other young patients to believe in themselves,” said Emmalee. “It can be hard dealing with health challenges, but I always think about those who have it worse than me. Instead of complaining about the things I can’t do, I celebrate all the things I can do.” “We can all learn from Emmalee’s enthusiasm, determination and positive outlook,” said Tony Slonim, MD, DrPH, President & CEO of Renown. “She has never met an obstacle too great or faced a challenge too difficult, and she effortlessly inspires others to view life through that same lens. Emmalee has already touched so many hearts here at Renown, and as our 2021 Champion Child Ambassador, her impact is sure to be incredible.”  Emmalee loves to talk to and help other children, especially when she visits Renown Children’s Hospital for treatments. One of her favorite things to do in the hospital is visit with other patients and try to make them feel better.  “Emmalee is very patient with all the doctors she sees, the medications she takes and the frequent lab testing and blood draws she receives,” said her mom, Ann Sutton. “She always remains positive and comforts those who think they are hurting her. This makes her quite the beloved patient at Renown Children’s Hospital!” Emmalee enjoys spending time with her four dogs and rabbit, and she also has an affinity for frogs, lizards and fish. She loves to sew and crochet, and for the past six years, she has held the title of top cookie-seller in her Girl Scout troop. When Emmalee grows up, she wants to be a pediatric nurse so she can help other kids who are going through what she has experienced. Her ultimate goal in life is to make the world a better place in many ways.  “From the moment I met Emmalee, I knew she was a champion,” said Kiemmy Thai, MBA, Foundation Manager of Children's Hospital at Renown. “Her courage and perseverance inspire so many pediatric patients with hope when they need it most. Her smile is contagious, and her words of wisdom at such a young age will have a great impact on our community. We are excited to work with Emmalee and help bring out the champion in others.” Emmalee will serve as Renown Children’s Hospital’s CMNH Champion Child for the next two years, acting as the face of the hospital in the community and sharing her heartwarming and inspiring story. Supporting Champions Like Emmalee Funds from the Children's Miracle Network Hospitals’ have helped purchase equipment for several of the subspecialists Emmalee needs to see. Additionally, Emmalee has benefited from equipment that CMNH has funded during her in-patient stays, such as distraction machines, iPads and CinemaVision goggles. You can support local champion children like Emmalee by visiting renown.childrensmiraclenetworkhospitals.org.   About Renown Children’s Hospital Renown Children’s Hospital is the only dedicated children’s hospital in northern Nevada, and offers a variety of programs and services designed specifically to care for the community's families. It has the region’s only Children’s ER and Pediatric ICU. Renown Children’s Hospital is the only hospital affiliated with Children’s Miracle Network Hospitals (CMNH) in the region and local CMN Hospitals' programs and events directly benefit children in the Truckee Meadows. It is also the only hospital in the region affiliated with CHA (Children’s Hospital Association). For more information, visit here. About Children’s Miracle Network Hospitals Children’s Miracle Network Hospitals® raises funds and awareness for 170 member hospitals that provide 32 million treatments each year to kids across the U.S. and Canada. Donations stay local to fund critical treatments and healthcare services, pediatric medical equipment and charitable care. Since 1983, Children’s Miracle Network Hospitals has raised more than $7 billion, most of it $1 at a time through the charity's Miracle Balloon icon. Its various fundraising partners and programs support the nonprofit's mission to save and improve the lives of as many children as possible. Find out why children's hospitals need community support, and learn about your member hospital, at CMNHospitals.org and facebook.com/CMNHospital.

Read More About Renown Children's Hospital Announces 2021 Children's Miracle Network Champion Child Ambassador

Together, will test over 30,000 qualifying study participants by 2023 for risk of cirrhosis and liver-related illnesses. Renown Institute for Health Innovation (IHI) announced today that the organization and Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™) Test to people with risks for nonalcoholic steatohepatitis (NASH) enrolled in the Healthy Nevada Project (HNP). The ELF Test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes and allow healthcare providers to intervene before irreparable damage occurs. This noninvasive blood test uses three serum biomarkers to create an ELF score from a predefined algorithm, which can be used by doctors to help evaluate if a patient requires increased medical care and monitoring for their condition. Nonalcoholic fatty liver disease (NAFLD), which includes NASH, is prevalent in Nevada and under-diagnosed, likely affecting more than 500,000 adult Nevadans. If undetected and untreated, NASH can result in liver cirrhosis and may require liver transplantation or lead to death. There are more than 12,000 people on a waitlist for liver transplantation in the U.S. and this number continues to rise due to the increasing prevalence of NAFLD. “Thanks to important data collected through our Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study, we now know that NASH is prevalent in the state of Nevada,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health. “We are proud to expand our partnership with Gilead and begin working with Siemens Healthineers to improve health of those with liver disease and to take early detection one step further by offering Enhanced Liver Fibrosis, ELF testing for patients of Renown Health. This test provides our team of highly-skilled physicians an advanced, noninvasive method to actively assess dynamic liver fibrosis in study participants and intervene whenever necessary, contributing to a healthier Nevada.”  “Gilead believes that noninvasive tests, including the ELF Test, will help improve the experience of people living with NASH. These tests may help to diagnose liver disease, monitor disease progression and evaluate responses to treatment without the requirement for liver biopsy,” said Rob Myers, MD, Vice President, Liver Fibrosis Clinical Research at Gilead Sciences. “The ELF Test has proven itself to be a valuable tool in NASH management and we hope this partnership will further support its use in routine care.”  “We are very pleased that NASH patients in the Healthy Nevada Project now have access to the ELF Test which offers clinically useful prognostic information for their condition with the convenience of a simple blood test. Using our advanced laboratory expertise together with Renown IHI and Gilead, we can work towards better understanding of NASH and liver disease in a representative patient population,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “We launched the Healthy Nevada Project to help people understand more about their health, to identify serious health risks, and to give people access to innovations like the ELF Test, so they can live their best lives,” said Renown’s chief scientific officer, Dr. Joseph Grzymski, who is also a research professor at the Desert Research Institute and principal investigator of the Healthy Nevada Project. It’s incredibly rewarding to be able to report clinical findings to help our 50,000 volunteer study participants, and to assist healthcare providers in helping their patients.” The provision of the ELF Test builds on a previously announced strategic collaboration between the Renown IHI and Gilead in July 2019. This ongoing partnership aims to collect and analyze de-identified genetic and electronic health data from 60,000 qualifying study participants to enhance the understanding of NAFLD and NASH and to potentially inform development of treatment options for these diseases.  About NAFLD and NASH NAFLD is a build-up of fat in the liver of people who do not have a history of alcohol misuse. It is normal for the liver to contain some fat, but if more than 5 percent of the liver content is fat, it’s considered a fatty liver (steatosis). NASH is the most severe form of NAFLD in which a person has liver cell damage and inflammation of the liver. Inflammation and liver cell damage can cause fibrosis, or scarring of the liver, and can cause decreased liver function (1). The symptoms of NASH are often silent or non-specific, making it difficult to diagnose. About one-third of people with NASH develop cirrhosis or irreversible liver damage (2). About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. For more information or to enroll, please contact RenownIHI@renown.org or (775) 982-6914. The Enhanced Liver Fibrosis (ELF™) Test kit is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.  In the U.S., the ELF Testing Service is available from Siemens Healthcare Laboratory, LLC (SHL), a CLIA-certified laboratory located in Berkeley, Calif. The ELF Testing Service, including the establishment of performance characteristics, was developed by SHL. The ELF Test has not been cleared or approved by the U.S. Food and Drug Administration. SHL is regulated under CLIA as qualified to perform high complexity testing. The ELF Test is used for clinical purposes and should not be regarded as investigational use only or research use only. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information visit, renown.org. About the Renown Institute for Health Innovation Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org. Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has over 60,000 participants. For more information, visit healthynv.org.  About Siemens Healthineers Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Further information is available at www.siemens-healthineers.com.Media Contact for Siemens Healthineers: Lance LongwellM: 610-448-6341E: lance.longwell@siemens-healthineers.com

Read More About Renown Institute Expands Partnership to Offer ELF Testing

A major community investment in health care facilities to transform care, improve economy and enhance the quality of life for generations to come. Renown Health announced today $469 million in planned investments, including hospital campus improvements and new health care facilities across northern Nevada to meet the growing community need over the next three years. “Renown Health has a rich 158-year history in serving northern Nevada. Continuing our bold vision and legacy, Renown is making this investment to transform care in our community and improve the quality of life for generations to come. Nothing of its kind has been imagined or currently exists in our area,” says James DeVolld, Board Chair, “The transformation of our hospital campuses represents one of the single largest investments in health care facilities, services and programs in the state, and are a result of putting people first to enhance health care access, experiences, outcomes and affordability for everyone in our community. This will improve care and it will have a tremendous, positive effect on our local and statewide economy."  “Like those we serve, we have experienced many challenges in 2020,” says Tony Slonim, MD, DrPH, President and CEO, Renown Health. “These challenges confirmed the critical role that Renown plays as a locally-owned, not-for-profit integrated health network. We are passionate about stepping up to serve our community at all times, and especially when we are needed most. We are transforming to meet the needs of our growing community today- and for the future.” GROWING FOR THE COMMUNITY Over the last two years, given significant consumer demand for Renown providers and services, a master facilities planning process was undertaken to ensure that Renown has adequate bed and procedure capacity, spaces to accommodate new technology and services to meet the needs of a growing patient base and community.  “Renown’s campuses will be innovative, convenient, safe and compassionate places to provide and receive care, incorporating modern efficiencies in a healing environment, says Dawn D. Ahner, DSc, FACHE, Chief Operating Officer, Acute Services at Renown. “Designed for patients, visitors and team members, these spaces will showcase state-of-the-art technology, enhance patient safety and improve the hospital experience- including adding more private rooms; having flexible areas with room for growth; and healthy, sustainable buildings and interiors.” Today, the population of Washoe County, now at 473,156 people, has experienced staggering growth of 12.28% over the last 10 years, from 2010 to 2020. According to the U.S. Census Bureau, Nevada ranks as one of the top fastest-growing states in the country, with 15.21% growth over the last ten years. BENEFITS OF MASTER FACILITY PROJECT To alleviate current capacity constraints, allow for expansion and new services, a number of aging facilities will be replaced and new patient care areas will be constructed. Overall, the master facilities project enhances the clinical care model, enhances the experience for patients, families and staff and improves the infrastructure of the physical plant. COMPONENTS: RENOWN REGIONAL TAHOE TOWER BUILD OUT & RENOVATION; REGIONAL SIERRA RENOVATION Renown Children’s Hospital at Renown Regional Medical Center, 1155 Mill St., Reno, NV An expanded Neonatal Intensive Care Unit (NICU) with increased capacity from 39 current to 49 bassinets on Level 5 of Tahoe Tower of Renown Medical Center. An expanded Pediatric Intensive Care Unit (PICU) with increased capacity from 11 to 16 private patient and family rooms on Level 5 of the Tahoe Tower of Renown Regional Medical Center. A new Renown Children's Hospital in-patient floor with improvements, upgrades and increased capacity from 33 to 38 private patient and family rooms with a total capacity of 58 pediatric beds on Level 4 of Tahoe Tower of Renown Regional Medical Center. Renown Regional Medical Center, 1155 Mill St., Reno, NV Renown Regional Tahoe Tower Build Out & Renovation A new surgical trauma Intensive Care Unit (ICU) on Level 9 in the Tahoe Tower, increasing capacity to 34 private patient rooms. Improvements and upgrades for Levels 3, 6, 7, 8, of Tahoe Tower. Improvement of 'family zone' within patient rooms; addition of USB capabilities, furnishings. New Respite room for health care team. Upgraded technology/infrastructure to improve collaboration between caregivers and family members. Improvement in lighting, with dimmable options for patient rooms and LED/sustainable improvements. Renown Regional Sierra Tower Renovation Improvements and upgrades for the Sierra Tower Intensive Care Unit (ICU) Level 1, Sierra Tower. Improvements and upgrades for an Adult Transitional Care Unit and Medical/Surgical Unit on Level 4 of Sierra Tower. Renown Regional Material Management and Kitchen Building Renown Regional CUP (Central Utility Plant) Building RENOWN SOUTH MEADOWS RENOVATION & SPECIALTY CARE CENTER Renown South Meadows Medical Center, 10101 Double R Blvd, Reno, NV A new façade, entry canopy and upgrade of lobby and public spaces, including a new Family Lounge. Improvements and upgrades for Medical Center, Levels 1, 2, 3 with private patient/family rooms, USB capabilities, furnishings. Welcome Lounges for patients and families, Respite room for health care team. Expansion of surgery minor procedures room. Operating room enhancements, technology integration and lounges. Improvement in lighting, with dimmable options for patient room areas, LED/sustainable improvements. Improvements, upgrades and new services to the South Meadows Medical Office Building including imaging, surgical pre-admission lounge and expanded Outpatient Therapy space. A new Ambulatory Center adjacent to surgery for convenient procedural care. A new Specialty Care Center. Level 1 will feature kitchen/dining facilities, expanded laboratory and diagnostic services, including Interventional Radiology and a new Cardiac Catheterization Lab. Level 2 will feature an Ambulatory Surgery Center and expanded sterile processing department.  “Structural quality and resiliency are of utmost importance as we are designing our facilities for extreme weather conditions that our region may face,” says Steve Horn, Vice President, Real Estate and Facilities. “As environmental stewards, we are designing the rooms in ways that reduce energy needs, allow for natural light and comfortable temperatures. The interior design will have healing and comfort at the forefront with thoughtful places for reflection, architecture, healing art and views that inspire.” Sy Johnson, MBA, chief of staff for Renown added, “We are working tirelessly to improve the health- and the lives- of thousands of people for the better, to care for people both in sickness and in health, and to provide better quality health and healthcare services in modern, convenient and attractive facilities, at a lower cost and with improving access to services.”  THE TEAM The planning and design team for the Renown master facilities project includes a number of locally-owned businesses, as well as veteran and female-owned businesses.  Leading Architect: Perkins + Will, Chicago, IL For more than sixty-five years, Perkins and Will’s vision and compassion have helped shape many of the nation’s most progressive academic medical centers, research institutions, community hospitals, and clinics. The breadth and quality of their diverse, global portfolio have consistently placed them among the leading healthcare firms in the world. Leading Engineer: WSP, Montreal, CA WSP provides complete healthcare consulting services in the design of mechanical, electrical, plumbing, structural, building technology and fire protection systems; with a focus on sustainable and high performance building design.  Structural Engineer: Datum, San Antonio, TX Datum has an 80-year history providing engineering services for a large variety of projects types. Datum has an experienced team whose tenures with the firm averages more than 20 years.  Electrical Engineer: PK Electrical, Reno, NV, Female-Owned Business PK Electrical, Inc. is a self-performing, female-owned electrical engineering firm providing complete electrical and low voltage design for power, lighting, communications, medium voltage distribution, and emergency power systems. Mechanical Engineer: Ainsworth Associates, Reno, NV Representing a body of work spanning more than seven decades, Ainsworth Associates Mechanical Engineers has built a solid foundation for quality in design for even the most complex building requirements. Civil Engineer: Wood Rodgers, Reno, NV Wood Rodgers has a long standing history partnering with Renown Health. With just under 100 employees in their Reno office alone, they bring local expertise in land planning, civil and geotechnical engineering, surveying, and mapping to better the community we call home.  Traffic Study: Headway Transportation, Reno, NV Headway Transportation was founded in 2010 to provide clients exceptional service and value across all facets of transportation planning & traffic engineering. They have extensive experience across northern Nevada.  Medical Equipment: Covalus, Medical Equipment, Veteran-Owned Small Business Covalus is a veteran-owned small business (VOSB) specializing in healthcare construction management and initial outfitting and transition. In the past twenty years, Covalus has become one of the leading national firms in planning, budgeting, and executing healthcare and other facility projects, working for government, academic, and private institutions across 32 states and 5 countries. Renown has secured long-term financing for this master facilities project. Renown has engaged a firm to coordinate the bidding process in order to be transparent and unbiased in the selection process. Construction is slated to begin in spring 2021 with a majority of the project completed by fall 2023.   About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project® . For more information visit, www.renown.

Read More About Renown Announces $469 Million in Planned Investments

Renown's Medications to Go program offers time-savings and convenience for patients and their families. It can be difficult leaving the hospital after a stay. Learning and understanding detailed care instructions and settling in to a new routine, can be an overwhelming experience for both patients and their caregivers. Plus, there’s the added inconvenience of visiting the pharmacy to pick up prescribed medications.  Because it is so inconvenient, one-third of these prescriptions never reach the patient, and remain in a basket at the pharmacy, awaiting pick-up. Because the patient never takes their medication, recovery time can take longer, and in some cases, the patient goes without the needed medications and may be readmitted to the hospital.   To make the process more convenient for patients and their families, Renown Pharmacy now offers a new Medications to Go program.  Patients can now receive Medications to Go at Renown hospitals. Opting in when they arrive, and the day they leave, their medication will be hand-delivered to them in their room by a member of Renown’s pharmacy team, along with medication counseling by a Renown pharmacist. There is no additional cost for patients to use this service aside from their normal medication copays. “Medications to Go is another example of how we are using new approaches to deliver an excellent patient and customer experience, and helping people choose, access, experience and prefer Renown Health providers and hospitals,” said Tony Slonim, MD, DrPH, president and CEO of Renown. “We want to help our patients on their journey to health and wellness.”  The Renown Pharmacy team has been recognized for several national best practice programs. A similar pilot program showed a 25 percent reduction in hospital readmission rates for patients with Medicaid insurance, emphasizing the need for the service for all patients at all Renown hospital locations. Since June 1, 2020, Medications to Go has been available to every patient at Renown Regional Medical Center, Renown South Meadows Medical Center and Renown Rehabilitation Hospital. “We’ve filled more than 1,600 prescriptions through the program to date,” said Adam Porath, Doctor of Pharmacy, and Renown’s interim director. “Patients are very happy – especially new moms and parents of our youngest patients at Renown Children’s Hospital.”      About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Renown Pharmacy Introduces New Program: Medications to Go

Presented by the Desert Research Institute and Renown Health, DANA will help people learn more about the Healthy Nevada Project® and their own unique, genetic health traits What is the Healthy Nevada Project®? What are the benefits of joining this research study? How can I find out if I carry genes for health risks like heart disease, hereditary breast and ovarian cancer syndrome and Lynch syndrome? What if a holographic avatar, powered by artificial intelligence (AI), could answer all these questions and more? DANA has all the answers, she is a virtual assistant with “DNA” in her name, presented by the Renown Institute for Health Innovation (Renown IHI), a collaboration between Renown Health and the Desert Research Institute (DRI). This life-sized, holographic avatar will greet individuals outside Renown Regional Medical Center’s Sierra Café, and talk to them about the Healthy Nevada Project, the world’s largest community-based genetic population health study. Members of the media are invited to meet DANA this morning from 10 a.m. – noon. Please reply to this email or call (775) 691-7308 to coordinate a meet and greet. “Unfortunately, Nevada ranks among the lowest in the nation for health outcomes—and we are working to change that,” said Anthony Slonim, M.D., D.Ph., president and CEO of Renown Health and president of Renown Institute for Health Innovation. “Through the Healthy Nevada Project® , our goal is to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile. Thanks to this advanced technology, DANA will offer people a personalized explanation of the Project, and help them take the next step to better understand their health, and their health risks, so they can modify their behavior and ultimately, live a healthier, happier life.” With more than 51,000 study participants enrolled to date, the Healthy Nevada Project® is considered the fastest-enrolling genetic study in the country. The Project is also the first of its kind to return clinical results to study volunteers, which means participants can learn their genetic risks tied to heart disease and certain cancers, as well as lifestyle changes that could potentially help reduce their risk and prevent disease. Furthermore, participants can choose to share their information with their medical provider to improve and enhance their medical care. “We are always happy to engage with our study participants and look forward to having them meet and engage with DANA,” said Joseph Grzymski, Ph.D., research professor at DRI, principal investigator of the Healthy Nevada Project® and chief scientific officer for Renown Health. “At a time of physical distancing and limiting human contact where possible, using tools like an avatar and AI are important for communicating, whether it be for genetics, vaccinations or other important health information.” Visitors can interact with DANA through a touch screen (cleaned and sanitized after every encounter) to learn more about the study, enter their contact information and schedule an appointment to join the free genetics study or receive more information about their test results. Kiosk visitors are asked to maintain physical distance guidelines and use the hand sanitizer and Sani Wipes available next to the kiosk.     Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org.

Read More About Introducing Dana Renown Institute for Health Innovations New Life Sized Holographic Kiosk